» Authors » G Johnsen

G Johnsen

Explore the profile of G Johnsen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 675
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nilsson K, Klevebro F, Sunde B, Rouvelas I, Lindblad M, Szabo E, et al.
Ann Oncol . 2023 Sep; 34(11):1015-1024. PMID: 37657554
Background: The optimal time to surgery (TTS) after neoadjuvant chemoradiotherapy (nCRT) for oesophageal cancer is unknown and has traditionally been 4-6 weeks in clinical practice. Observational studies have suggested better...
2.
Sunde B, Klevebro F, Johar A, Johnsen G, Jacobsen A, Glenjen N, et al.
Br J Surg . 2019 Aug; 106(11):1452-1463. PMID: 31436322
Background: There are few data comparing health-related quality of life (HRQoL) after neoadjuvant chemotherapy alone (nCT) compared with neoadjuvant chemoradiotherapy (nCRT) in patients with oesophageal cancer. Methods: In the NeoRes...
3.
A von Dobeln G, Klevebro F, Jacobsen A, Johannessen H, Nielsen N, Johnsen G, et al.
Dis Esophagus . 2018 Aug; 32(2). PMID: 30137281
NeoRes I is a randomized phase II trial comparing neoadjuvant chemoradiotherapy with neoadjuvant chemotherapy in the treatment of resectable cancer of the esophagus or gastroesophageal junction. Patients with biopsy-proven adenocarcinoma...
4.
Sunde B, Johnsen G, Jacobsen A, Glenjen N, Friesland S, Lindblad M, et al.
Dis Esophagus . 2018 Aug; 32(2). PMID: 30084992
Dysphagia is the most significant symptom in patients with esophageal cancer. There are different therapeutic interventions designed to relieve dysphagia, but few studies have addressed the effects of neoadjuvant therapy....
5.
Klevebro F, Alexandersson von Dobeln G, Wang N, Johnsen G, Jacobsen A, Friesland S, et al.
Ann Oncol . 2016 Jan; 27(4):660-7. PMID: 26782957
Background: Neoadjuvant therapy improves long-term survival after oesophagectomy, treating oesophageal cancer, but the evidence to date is insufficient to determine which of the two main neoadjuvant therapy types, chemotherapy (nCT)...
6.
Klevebro F, Johnsen G, Johnson E, Viste A, Myrnas T, Szabo E, et al.
Eur J Surg Oncol . 2015 Apr; 41(7):920-6. PMID: 25908010
Objective: To compare the incidence and severity of postoperative complications after oesophagectomy for carcinoma of the oesophagus and gastro-oesophageal junction (GOJ) after randomized accrual to neoadjuvant chemotherapy (nCT) or neoadjuvant...
7.
Berge J, Batnes A, Johnsen G, Blackwell S, Moline M
Mar Biol . 2014 Feb; 159(1):231-237. PMID: 24489409
This study examines the composition and activity of the planktonic community during the polar night in the high Arctic Kongsfjord, Svalbard. Our results are the first published evidence of bioluminescence...
8.
Jovine R, Johnsen G, Prezelin B
Photosynth Res . 2013 Dec; 44(1-2):127-38. PMID: 24307032
We have isolated Chl a-Chl c-carotenoid binding proteins from the dinoflagellates Prorocentrum minimum and Heterocapsa pygmaea grown under high (500 μmol m(-2) s(-1), HL) and low (35 μmol m(-2) s(-1),...
9.
Shikora S, Toouli J, Herrera M, Kulseng B, Zulewski H, Brancatisano R, et al.
J Obes . 2013 Aug; 2013:245683. PMID: 23984050
Background: An active device that downregulates abdominal vagal signalling has resulted in significant weight loss in feasibility studies. Objective: To prospectively evaluate the effect of intermittent vagal blocking (VBLOC) on...
10.
Bringeland E, Wasmuth H, Johnsen G, Johnsen T, Juel I, Mjones P, et al.
J Surg Oncol . 2013 Jan; 107(7):752-7. PMID: 23335125
Objectives: To evaluate the outcomes among patients treated for gastric adenocarcinoma in a referral hospital, and to identify possible trends during the last decade. Methods: All patients evaluated for gastric...